HXHaibo Xiao

Haibo Xiao

*This is an algorithmically generated author record based on publicly available information.

Haibo Xiao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Pan

    Department of Endodontics, Changsha Stomatological Hospital, Changsha, China

    3 shared publications
  • Honghui Xie

    Department of Endodontics, Changsha Stomatological Hospital, Changsha, China

    3 shared publications
  • Zhijian Su

    Department of Endodontics, Changsha Stomatological Hospital, Changsha, China

    3 shared publications
  • Fengqing Hu

    Department of Cardiothoracic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Shuangjiang Li

    Department of Endodontics, Changsha Stomatological Hospital, Changsha, China

    2 shared publications
  • Xiao Xie

    Department of Cardiothoracic Surgery Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Effect of nano-hydroxyapatite filling on masticatory function and gingival sulcular fluid inflammatory factor levels in periapical inflammation

    by Honghui Xie, Aihong Tan, Zhijian Su, Chao Pan, Shuangjiang Li, Haibo Xiao

    The purpose of this study is to investigate the influence of nano-hydroxyapatite (nano-HA) filling on the restoration of masticatory function and the modulation of inflammatory factors within gingival sulcular fluid in patients suffering from periapical inflammation. 98 patients with periapical inflammation were selected and divided into a control group and a nano group using the red blue ball method, with 49 cases in each group. The control group was treated with conventional root canal therapy only, and the nano group underwent endodontic treatment with the nano-HA filling method. Gingival fluid samples were collected from all patients at enrollment, 1 week, and 3 months postoperatively to analyze the levels of interleukin- 1β (IL- 1β) and tumor necrosis factor-α (TNF-α). At the time of enrollment and 3 months after surgery, patients were monitored for bite force, masticatory efficiency, and clinical efficacy. In this study, compared to the control group, the experimental group treated with nano-HA filling showed significantly better improvement in bite force and masticatory efficiency, with the difference being statistically significant (P < 0.01). Moreover, the experimental group significantly inhibited the expression of inflammatory factors such as IL- 1β and TNF-α, with a continuous decrease in their levels over time. In terms of filling effect, healing rate, and total efficacy rate, the experimental group also achieved superior results compared to the control group, with the difference being statistically significant (P < 0.05). There was a negative correlation between the application of nano-HA fillers and the gingival sulcus inflammatory factor at 1 week postoperatively and 3 months postoperatively. In comparison with conventional restorative materials, nano-HA restorative has been shown to possess several notable advantages. These include the promotion of recovery of masticatory function, the regulation of inflammatory factor expression in gingival sulcular fluid, and the enhancement of clinical efficacy and filling effect. This study provides a theoretical basis for the clinical promotion of the use of nano-HA restorative materials in the treatment of periapical inflammation.


  • Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634

    by Chao Pan, Zhijian Su, Honghui Xie, Yanyang Ning, Shuangjing Li, Haibo Xiao

    It has been demonstrated that circular RNA (circRNA) is involved in the progression of tongue squamous cell carcinoma (TSCC). The aim of this study was to investigate the intrinsic mechanism of circ_0081069 in TSCC progression. The expression levels of circ_00081069, miR-634, and mitogen-activated protein kinase kinase 4 (MAP2K4) in TSCC tissues and cells were detected by quantitative real-time PCR (qRT-PCR). Cell counting kit 8 assay, Edu assay, and flow cytometry assay were used to detect cell proliferation and cell cycle distribution. Transwell assay was used to detect cell migration and invasion abilities. Western blot analysis was performed to detect the protein expression. Dual-luciferase reporter assay was used to detect the targeting relationships of circ_0081069, miR-634 and MAP2K4. Immunohistochemical staining was used to measure MAP2K4-positive cells in tissues. The effect of circ_0081069 silencing on tumor formation in TSCC in vivo was explored by xenograft tumor assay. Circ_0081069 was highly expressed in TSCC tissues and cells. Silencing of circ_0081069 inhibited cell proliferation, cell cycle progress, cell migration and invasion in vitro, as well as hindered tumor growth in vivo. Mechanistically, circ_0081069 targeted miR-634 to negatively regulate miR-634 expression, and inhibition of miR-634 was able to weaken the inhibitory effect of circ_0081069 knockdown on proliferation, migration, and invasion of TSCC cells. MiR-634 targeted MAP2K4 and negatively regulated MAP2K4 expression, and overexpression of miR-634 inhibited TSCC cell proliferation, migration, and invasion, while co-overexpression of MAP2K4 was able to reverse the effects of miR-634 in TSCC cells. Circ_0081069 is involved in the regulation of proliferation, cycle progress, migration, and invasion of TSCC cells through the miR-634/MAP2K4 axis and has the potential to serve as a diagnostic biomarker and therapeutic target.


  • Open Access

    Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma

    by Zhijian Su, Chao Pan, Honghui Xie, Yanyang Ning, Shuangjiang Li, Haibo Xiao

    Background: Increasing evidence demonstrated the important roles of circular RNAs (circRNAs) in human cancer progression, including oral squamous cell carcinoma (OSCC). The study intentions were to explore the role and molecular mechanism of hsa_circ_0004390 (circLPAR3) in OSCC progression.Methods: Expression of circLPAR3 in collected samples and cultured cell lines was detected with real‐time quantitative reverse transcription‐polymerase chain reaction (RT‐qPCR). Loss‐of‐function experiments were performed to determine the effect of circLPAR3 silencing on OSCC cell proliferation, migration, invasion, apoptosis, angiopoiesis, and glycolysis. The sponge function of circLPAR3 was predicted by bioinformatics analysis and validated by the dual‐luciferase reporter and RNA pull‐down assays. In vivo experiments were conducted to validate the function of circLPAR3.Results: A marked increase in circLPAR3 expression was observed in OSCC samples and cell lines. Furthermore, circLPAR3 could distinguish OSCC samples from paired non‐tumor samples, and patients with high circLPAR3 expression had a poor prognosis. Furthermore, circLPAR3 inhibition decreased OSCC growth in xenograft mouse models. Moreover, circLPAR3 silencing repressed cell proliferation, migration, invasion, angiopoiesis, glycolysis, and induced cell apoptosis in OSCC cells in vitro. Mechanically, circLPAR3 sponged miR‐144‐3p to prohibit the inhibiting effect of miR‐144‐3p on LPCAT1, thus promoting OSCC progression.Conclusion: CircLPAR3 exerted a tumor‐promoting effect on OSCC growth through elevating LPCAT1 expression via functioning as a miR‐144‐3p sponge. This study supports the possible role of circLPAR3 in the diagnosis, prognosis, and treatment of OSCC.


  • Open Access

    LncRNA RP11-465B22.8 triggers esophageal cancer progression by targeting miR-765/KLK4 axis

    by Rui Hu, Rui Bi, Lianyong Jiang, Haibo Xiao, Xiao Xie, Hongtao Liu, Fengqing Hu

    LncRNAs play an important role in tumorigenesis and progression; however, the function and mechanisms of lncRNAs in esophageal cancer (EC) remain largely unclear. In this study, we screened the differentially expressed lncRNAs in EC by using RNA-seq and one of the most upregulated lncRNAs, lncRNA RP11-465B22.8, was further characterized. LncRNA RP11-465B22.8 was upregulated in EC tissues and high lncRNA RP11-465B22.8 expression was associated with poor survival of EC patients. Ectopic expression of lncRNA RP11-465B22.8 enhanced the proliferation, migration, and invasion of EC cells, whereas knockdown of lncRNA RP11-465B22.8 led to the opposite effects. Mechanistically, lncRNA RP11-465B22.8 sponged miR-765 to increase the expression of KLK4. Moreover, LncRNA RP11-465B22.8 could be delivered from EC cells to macrophages via exosomes and subsequently induced M2 macrophage-induced cell migration and invasion. Our findings revealed a novel lncRNA RP11-465B22.8/miR-765/KLK4 pathway in EC and indicated that lncRNA RP11-465B22.8 might be a potential target for EC therapy.